There are 2934 resources available
7194 - Phase II Study of Neoadjuvant Cemiplimab Prior to Surgery in Patients with Stage III/IV (M0) Cutaneous Squamous Cell Carcinoma of the Head and Neck (CSCC-HN)
Presenter: Neil Gross
Session: Poster Discussion – Melanoma and other skin tumours
Resources:
Abstract
1739 - 18-months relapse-free survival (RFS) and biomarker analyses of OpACIN-neo: a study to identify the optimal dosing schedule of neoadjuvant (neoadj) Ipilimumab (IPI) + Nivolumab (NIVO) in stage III melanoma
Presenter: Elisa Rozeman
Session: Poster Discussion – Melanoma and other skin tumours
Resources:
Abstract
7257 - Can tocotrienol reduce time to the first serious adverse event during treatment with FOLFOXIRI for colorectal cancer?
Presenter: Louise Raunkilde
Session: Poster Discussion – Supportive and palliative care
Resources:
Abstract
1647 - Primary analysis results of randomized controlled trial evaluating reactive topical corticosteroid strategies for the facial acneiform rash by EGFR inhibitors (EGFRIs) in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC) -FAEISS study-
Presenter: Naoya Yamazaki
Session: Poster Discussion – Supportive and palliative care
Resources:
Abstract
Poster Discussion – Supportive and palliative care - Invited Discussant LBA37, LBA90 and 1758PD
Presenter: Anton Snegovoy
Session: Poster Discussion – Supportive and palliative care
Resources:
Slides
Webcast
Poster Discussion – Supportive and palliative care - Invited Discussant 1597PD and 1617PD
Presenter: Stein Kaasa
Session: Poster Discussion – Supportive and palliative care
Resources:
Slides
Webcast
Presentation of case/condition: Review of novel agents licensed for use in the 21st century
Presenter: Udai Banerji
Session: Is randomisation of clinical trials still the gold standard?
Resources:
Slides
Webcast
Why we need randomization
Presenter: Urania Dafni
Session: Is randomisation of clinical trials still the gold standard?
Resources:
Slides
Webcast
The voice of the regulator (EMA)
Presenter: Francesco Pignatti
Session: Is randomisation of clinical trials still the gold standard?
Resources:
Slides
Webcast
How non-randomized studies can lead to registration
Presenter: Christophe Massard
Session: Is randomisation of clinical trials still the gold standard?
Resources:
Slides
Webcast